immunology

We cordially invite you to join us live on May 17 as we work together to accelerate the globalization of China’s innovative drugs. See you online!

If you are looking for brain-penetrating JAK1/TYK2 inhibitors, please contact DrugTimes BD Team at BD@drugtimes.cn asap

Congratulations to Lilly and Morphic! This acquisition will expand Lilly’s immunology pipeline with oral integrin therapies